Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   


[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

Items 1 to 30 of 91 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
Axon ID Name Description From price
1831 A 66 PI3K inhibitor (p110-α specific) €95.00
2857 Acalisib PI3K inhibitor (p110 δ specific) €120.00
2540 Akt Inhibitor VIII Inhibitor of Akt1 and 2 with significant off-side effects (CaMKIα and AhR) €95.00
2925 Alpelisib PI3K inhibitor (p110-α specific) €90.00
3827 AMG-511 Orally bioavailable, highly potent and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor Inquire
1424 AS 252424 PI3K inhibitor (p110-γ specific) €85.00
1436 AS 252424 bispotassium salt PI3K inhibitor (p110-γ specific) €95.00
2748 Autophinib PIK3C3/Vps34 inhibitor €120.00
3996 AZD2014 Orally bioavailable dual mTORC1/mTORC2 inhibitor Inquire
3808 AZD3458 Orally bioavailable potent and selective PI3Kγ inhibitor Inquire
1859 AZD5363 dihydrochloride Inhibitor of protein kinase B (Akt) €90.00
2926 AZD6482 PI3K inhibitor (p110 β specific) €120.00
1561 AZD8055 mTOR inhibitor €80.00
3690 AZD8186 PI3Kβ/δ isoform-selective inhibitor Inquire
3055 B591 Potent, specific class I PI3K inhibitor €125.00
1282 BAG 956 PI3K and PDPK1 inhibitor €95.00
3778 BAY-091 First potent and highly selective PIP4K2A inhibitor €130.00
3598 BAY-091 hydrochloride First potent and highly selective PIP4K2A inhibitor €130.00
3942 BAY-1082439 PI3Kα/β-balanced inhibitor Inquire
1281 BEZ 235 PI3K and mTOR tyrosine kinase inhibitor €50.00
1390 BX 795 PDPK1, TBK1 and IKK inhibitor €60.00
3350 BX 795 hydrochloride PDPK1, TBK1 and IKK inhibitor €80.00
1130 BX 912 PDPK1 inhibitor €80.00
2170 CAL 101 PI3K inhibitor (p110 δ specific) €95.00
4038 CEP-37440 hydrochloride Potent, selective and orally active inhibitor of ALK anf FAK Inquire
2039 CZC 24832 PI3K inhibitor (p110-γ specific) €95.00
1719 D 106669 Potent and selective PI3K inhibitor €85.00
1239 Deguelin Akt inhibitor €95.00
2630 eCF309 Highly selective and potent inhibitor of mTOR signalling €85.00
4149 Everolimus Selective and orally active mTOR1 inhibitor  Recently added Inquire

Items 1 to 30 of 91 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
Please wait...